NEWARK, Del, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global fructosamine test market was valued at around US$ 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period.

Quadintel published a new report on the Fructosamine Reagents Market. The research report consists of thorough information about demand, growth, opportunities, challenges, and restraints. In addition, ...

Fructosamine testing is used to monitor a person’s blood glucose level if they have diabetes mellitus. It is also useful in determining the efficacy of changes in one’s diabetic treatment plan, such ...

The global fructosamine reagents market is expected to witness significant growth over the forecast period owing to increasing adoption of the fructosamine reagents for assays. By disease type, the ...